Trials / Completed
CompletedNCT06161246
A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction
An Open-label, Randomized, Split-face, Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, single-center, randomized, split-face, controlled study to assess the effect of comfort intervention on pain during treatment injection compared against non-comfort intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vibrating Beauty Bar | A vibrating beauty bar will be used at the injection site for patient comfort. |
Timeline
- Start date
- 2023-10-23
- Primary completion
- 2024-02-15
- Completion
- 2024-02-15
- First posted
- 2023-12-07
- Last updated
- 2024-03-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06161246. Inclusion in this directory is not an endorsement.